Clicky

PURETECH HEALTH PLC LS 1(0VQ) News

Date Title
May 22 PureTech to Present at the Jefferies Global Healthcare Conference
May 20 PureTech’s Deupirfenidone (LYT-100) Demonstrates Strong and Durable Efficacy as a Monotherapy with Favorable Tolerability in Phase 2b ELEVATE IPF Trial
Apr 23 PureTech Health: Notice of Results
Mar 11 PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair